Published in J Psychiatr Res on April 21, 2011
Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder. Drugs Context (2015) 0.75
The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor. Eur J Clin Pharmacol (2013) 0.75
Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care (2006) 3.47
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain (2005) 2.10
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med (2005) 1.99
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. J Womens Health (Larchmt) (2007) 1.69
Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res (2007) 1.45
An affective circumplex model of neural systems subserving valence, arousal, and cognitive overlay during the appraisal of emotional faces. Neuropsychologia (2008) 1.32
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13
Hepatic effects of duloxetine-I: non-clinical and clinical trial data. Curr Drug Saf (2008) 1.13
18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors. J Nucl Med (2011) 1.11
Ca2+ influx-independent synaptic potentiation mediated by mitochondrial Na(+)-Ca2+ exchanger and protein kinase C. J Cell Biol (2003) 1.11
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb) (2011) 1.08
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety (2008) 1.07
The ghost condition: imitation versus emulation in young children's observational learning. Dev Psychol (2004) 1.06
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med (2008) 1.06
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 1.01
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder. J Clin Psychiatry (2007) 1.00
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med (2006) 0.98
HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. Eur J Immunol (2012) 0.97
Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci (2002) 0.96
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. Int Clin Psychopharmacol (2007) 0.96
Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole. Cancer Biol Ther (2007) 0.95
Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo. J Pharmacol Exp Ther (2004) 0.93
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. Pain Med (2007) 0.93
Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy. Curr Treat Options Neurol (2005) 0.93
A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status. Int J Radiat Biol (2008) 0.93
Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med (2011) 0.92
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Med (2007) 0.92
Targeting hypoxia and angiogenesis through HIF-1alpha inhibition. Cancer Biol Ther (2005) 0.92
Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Depress Anxiety (2008) 0.91
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events. Curr Drug Saf (2008) 0.91
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain (2009) 0.90
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography. Eur J Nucl Med Mol Imaging (2009) 0.89
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Atten Defic Hyperact Disord (2009) 0.89
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biol Blood Marrow Transplant (2002) 0.88
Looking for episodic memory in animals and young children: prospects for a new minimalism. Neuropsychologia (2008) 0.88
Guidance on patient identification and administration of recombinant human activated protein C for the treatment of severe sepsis. Can J Infect Dis (2002) 0.88
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res (2008) 0.87
Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy. Cochrane Database Syst Rev (2008) 0.87
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. J Clin Psychiatry (2010) 0.87
A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression. J Psychiatr Res (2009) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status. Acta Oncol (2007) 0.86
On-mountain coverage of competitive skiing and snowboarding events. Curr Sports Med Rep (2011) 0.85
Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution. Int J Radiat Biol (2008) 0.84
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities. Biol Blood Marrow Transplant (2012) 0.83
Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.83
Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry. Radiother Oncol (2008) 0.82
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. Curr Med Res Opin (2007) 0.82
Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin (2011) 0.81
The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials. J Anxiety Disord (2009) 0.81
Pain response profile of patients with fibromyalgia treated with duloxetine. Clin J Pain (2010) 0.81
A region-specific increase in Galphaq and Galpha11 proteins in brains of rats during cocaine withdrawal. J Pharmacol Exp Ther (2003) 0.81
Short-term cocaine treatment causes neuroadaptive changes in Galphaq and Galpha11 proteins in rats undergoing withdrawal. J Pharmacol Exp Ther (2004) 0.81
5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences. Brain Res (2007) 0.80
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biol Psychiatry (2006) 0.80
Cannabis use and schizophrenia. Am J Psychiatry (2005) 0.78
Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model. Cancer Biol Ther (2009) 0.78
Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults. Cancer Chemother Pharmacol (2013) 0.78
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment. J Clin Psychopharmacol (2015) 0.78
Anthropogenic subsidies mitigate environmental variability for insular rodents. Oecologia (2012) 0.78
Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis (2013) 0.78
Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. J Affect Disord (2005) 0.78
Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder. Curr Med Res Opin (2015) 0.78
ALS Untangled No. 20: the Deanna protocol. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.77
Transmission of a follicular lymphoma by allogeneic bone marrow transplantation--evidence to support the existence of lymphoma progenitor cells. Br J Haematol (2006) 0.77
Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma. Leuk Lymphoma (2012) 0.77
Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms. Psychiatry (Edgmont) (2007) 0.77
Chimerical nature of the ribosomal RNA gene of a Nosema species. J Invertebr Pathol (2011) 0.77
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources. Curr Drug Saf (2008) 0.76
Effect of duloxetine in patients with fibromyalgia: tiredness subgroups. Arthritis Res Ther (2010) 0.76
Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart. J Diabetes (2014) 0.76
Predictive performance of a physiologically based pharmacokinetic model of busulfan in children. Pediatr Hematol Oncol (2014) 0.75
Genetics of critical illness: methodological issues. Crit Care Med (2002) 0.75
A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2014) 0.75
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment. J Clin Psychiatry (2016) 0.75
Overcoming barriers to developing seamless ST-segment elevation myocardial infarction care systems in the United States: recommendations from a comprehensive Prehospital 12-lead Electrocardiogram Working Group. J Electrocardiol (2009) 0.75
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies. Psychother Psychosom (2017) 0.75
IgM paraprotein interference with hemoglobin measurement using the CELL-DYN 3500. Vet Clin Pathol (2008) 0.75
Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Cancer Biother Radiopharm (2007) 0.75
Sequencing of production-scale synthetic oligonucleotides by enriching for coupling failures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem (2002) 0.75
The effects of phase duration on defibrillation success of dual time constant biphasic waveforms. Resuscitation (2009) 0.75
Relationship between TSH levels in the normal range and short-term duloxetine efficacy. J Affect Disord (2009) 0.75
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis. Clin Ther (2012) 0.75
Sequencing oligonucleotides by enrichment of coupling failures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Curr Protoc Nucleic Acid Chem (2006) 0.75